{"id":"W4404627081","doi":"10.1007/s13555-024-01295-w","title":"Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled Trials","year":2024,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Queen's University","funders":"UCB Pharma; XBiotech; National Institute for Health and Care Research; Sanofi; Manchester Biomedical Research Centre; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Scalp; Medicine; Dermatology; Randomized controlled trial; Psoriasis; Internal medicine; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001699849,0.0004527037,0.004852151,0.00110915,0.0001074754,0.00006370834,0.0001295909,0.0005959478,0.0008674418],"category_scores_gemma":[0.0003415882,0.0002844637,0.0007647162,0.000576591,0.0002819331,0.0001149239,0.00002742071,0.0002835301,0.00005575831],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003008424,"about_ca_system_score_gemma":0.00007298441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009544567,"about_ca_topic_score_gemma":0.0002218971,"domain_scores_codex":[0.9936269,0.004115977,0.001173711,0.0006047511,0.00004875474,0.0004299161],"domain_scores_gemma":[0.992276,0.00715761,0.0002286313,0.0002589329,0.0000249637,0.00005390624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7224464,0.001728615,0.06436556,0.00003222431,0.06348021,0.00105963,0.003390758,0.00001479598,0.009077313,0.001604251,0.0003812849,0.1324189],"study_design_scores_gemma":[0.9422317,0.0001710288,0.04147616,0.0001023501,0.005903413,0.0001847138,0.0001934365,0.0002476537,0.006218907,0.002229663,0.0005513813,0.0004895604],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8790656,0.1184807,0.00003735676,0.0004203497,0.000479859,0.001113795,0.0002754609,0.00007171978,0.00005507297],"genre_scores_gemma":[0.9781221,0.02060572,0.00003205975,0.0001107139,0.00004406278,0.0002317589,0.0007687825,0.00002152063,0.00006330192],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2197853,"threshold_uncertainty_score":0.9999608,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0164995437709476,"score_gpt":0.2978697981206246,"score_spread":0.2813702543496771,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}